Three Is Better than One: A Multimetal Complex that Triggers Immunogenic Cell Death
Angewandte Chemie International Edition · 2025
DOI: 10.1002/anie.202514351 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2025. Verfasst von Tomer Babu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, The University of Texas at Austin, 105 East 24th Street, Austin, Texas, 78712-1224, USA. Hauptthemen laut MEDLINE: Immunogenic Cell Death, Coordination Complexes, Antineoplastic Agents, Prodrugs. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Fulbright Association, Welch Foundation.
Abstract (Originalsprache)
Immunogenic cell death (ICD) is a form of regulated cell death capable of stimulating an adaptive immune response through release of damage‐associated molecular patterns (DAMPs). While several metal complexes have shown promise as ICD inducers, conjugates containing more than one metal center remain to be explored for ICD. Here, we report the design, synthesis, and evaluation of a tri‐metallic Au I ‐Pt IV ‐Ru II prodrug ( 5 ) that codelivers oxaliplatin (Type I ICD inducer), Ru II arene 2‐pyridinecarbothioamides (Type I), and Au(I) bis‐N‐heterocyclic (Type II) using a single scaffold. Upon reduction, complex 5 releases all three cytotoxic species, resulting in enhanced inhibition of thioredoxin reductase (TrxR1&2), elevated production of reactive oxygen species (ROS), and in vitro DAMP release. In vivo studies of complex 5 in a colorectal cancer mouse model demonstrated tumor growth suppression, reduced off‐target metal accumulation, and improved immune memory in a tumor challenge study compared to a 1:1:1 mixture of the constituent agents. Furthermore, peripheral white blood cell (WBC) profiling revealed that complex 5 activates both the innate and adaptive immune compartments. This study demonstrates an integrated chemo‐immunotherapeutic strategy that unifies multiple ICD triggers within a single prodrug framework. It thus highlights a promising approach to the creation of metal‐based multimodal anticancer therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, The University of Texas at Austin, 105 East 24th Street, Austin, Texas, 78712-1224, USA.
- Institute for Drug Research, School of Pharmacy, The Hebrew University of Jerusalem, Jerusalem, 9112102, Israel.
- Innovation for Health Institute, College of Pharmacy, The University of Texas at Austin, 1400 Barbara Jordan Blvd, Austin, Texas, 78723, USA.
ORCID-Profile: Tomer Babu, Matthew S Levine, Sourav Acharya, Jonathan L Sessler
Förderung
- NCI NIH HHS
- Fulbright Association
- Welch Foundation
- National Cancer Institute
Zitieren
APA
Babu, T., Levine, M. S., Acharya, S., Maier, E. Y., & Sessler, J. L. (2025). Three Is Better than One: A Multimetal Complex that Triggers Immunogenic Cell Death. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202514351
Vancouver
Babu T, Levine MS, Acharya S, Maier EY, Sessler JL. Three Is Better than One: A Multimetal Complex that Triggers Immunogenic Cell Death. Angewandte Chemie International Edition. 2025. doi:10.1002/anie.202514351
BibTeX
@article{Babu2025,
author = {Babu, Tomer and Levine, Matthew S and Acharya, Sourav and Maier, Esther Y and Sessler, Jonathan L},
title = {Three Is Better than One: A Multimetal Complex that Triggers Immunogenic Cell Death},
journal = {Angewandte Chemie International Edition},
year = {2025},
doi = {10.1002/anie.202514351}
}
EUVIMED